AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (951.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer

Zhuo Lua,b, Tianyu Hanc, Tao Wangb, Mingxi Ganb, Caifeng Xieb( ), Bentong Yud( ), Jian-Bin Wangb,d( )
College of Life Science, Nanchang University, Nanchang, Jiangxi 330031, China
School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi 330031, China
Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 352-355

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Lu Z, Han T, Wang T, et al. OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer. Genes & Diseases, 2023, 10(2): 352-355. https://doi.org/10.1016/j.gendis.2022.04.020

699

Views

10

Downloads

17

Crossref

16

Web of Science

16

Scopus

0

CSCD

Received: 28 February 2022
Published: 11 May 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).